FREE from: gluten, lactose, soy, sugar, egg, fish, crustaceans, nuts, peanuts, mustard, celery, sesame, sulphite, lupin, molluscs, genetically modified ingredients (GMO), artificial flavourings, colourings and flavour enhancers

Subcutaneous Injection Sites : Abdomen (2 inches from navel) Upper thighs Upper arms Near injury site (within 2-3 inches for localized healing) Intramuscular Options : Directly into affected muscle groups Shoulder deltoids Gluteal muscles Injection Equipment : 29-31 gauge insulin syringes 0.5-1ml capacity 12.7mm (1/2 inch) for subcutaneous 25mm (1 inch) for intramuscular Reconstitution Protocol BPC-157 typically comes as lyophilized powder requiring careful reconstitution: Use bacteriostatic water (0.9% benzyl alcohol) Add 2ml bacteriostatic water to 5mg vial Results in 2.5mg/ml concentration Gently swirl, avoid vigorous shaking Store reconstituted solution refrigerated Storage Requirements Unreconstituted : Room temperature, away from light and moisture Reconstituted : Refrigerate at 2-8C (36-46F) Stability : Use within 28 days of reconstitution Transport : Keep cool, avoid temperature extremes Optimal Timing and Administration Strategies Timing for Maximum Effectiveness Split Dosing Benefits : Dividing daily dose into 2-3 administrations maintains more consistent peptide levels and enhances healing throughout the day

This system mediates neuroprotection, synaptogenesis, cerebral blood flow, long-term potentiation and memory consolidation and retrieval
3 -cell dysfunction, characterized by impaired glucose-stimulated insulin secretion, increased apoptosis, and aberrant islet development, is commonly observed in patients with GDM
Studies reveal that patients who take GLP-1RAs have lower rates of pancreatitis compared to those who use other medications or no medication at all [9]
As consistency improves, many individuals notice that hydration, energy, and overall daily balance begin to feel more stable and predictable